Compare Rio Tinto (ADR) (RIO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Rio Tinto (ADR)Trade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Rio Tinto (ADR) vs State Street SPDR S&P Biotech ETF — how do they compare? Rio Tinto (ADR) trades at $102.19 (market cap $170.47B), while State Street SPDR S&P Biotech ETF trades at $159.9. The key difference: Rio Tinto (ADR) pays a 4.48% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.

	RIO	XBI
Market Cap	$170.47B	—
Sector	Industrials	Broad Market / Factor
52-Week High	$112.04	$169.55
52-Week Low	$61.98	$93.43
Enterprise Value	$183.82B	—
Dividend Yield	4.48%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rio Tinto (ADR)

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $161.97, down 1.12% today, with technical indicators showing mixed signals amid a bearish overall trend. The ETF holds over 150 biotech companies and has rallied 76% in the past year, driven by M&A activity and positive clinical trial catalysts. Analyst coverage remains limited with a single hold rating, while recent news highlights sector optimism around cancer vaccine breakthroughs and improved capital access.

Outlook remains cautiously optimistic with potential for 8-14% returns over 6-12 months, though high volatility and regulatory risks persist. Key opportunities include ongoing pharmaceutical M&A and innovation in immunotherapy, while risks center on sector-specific volatility and policy uncertainty.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RIO

Domestic Metals starts 9,000m drilling at Montana's Smart Creek copper project with Rio Tinto JVProactive Investors · 1 day agoBullish View details →

XBI

Biotech ETF IBB outperformed S&P 500 by 22 points in 3 months amid pharma patent cliff deals.24/7 Wall Street · 2 days agoBullish State Street SPDR S&P Biotech ETF (XBI) rated Buy with 8%-14% returns expected despite prior 76% rallySeeking Alpha · 4 days agoBullish View details →

About Rio Tinto (ADR)

Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.